Project 1: Microbiology of ME/CFS

项目1：ME/CFS微生物学

• 批准号: 10246406
• 负责人: W. Ian Lipkin
• 金额: $ 75.65万
• 依托单位: COLUMBIA UNIVERSITY HEALTH SCIENCES
• 依托单位国家: 美国
• 财政年份: 2017
• 资助国家: 美国
• 起止时间: 2017-09-22 至 2022-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10246406
• 关键词: Address; Agonist; Antibiotics; Antibodies; Antiviral Agents; Autoantibodies; B-Lymphocytes; Bacteria; Base Sequence; Biological Assay; Biological Markers; Blood; Chronic Fatigue Syndrome; Communities; Data; Diagnosis; Disease; Double-Stranded RNA; Failure; Herpesviridae; High-Throughput Nucleotide Sequencing; Immune Plasma; Immune response; Immunity; Infection; Infectious Agent; Inflammation; Intervention; Intravenous infusion procedures; Laboratories; Lead; Methods; Microbe; Microbiology; Monoclonal Antibodies; Natural Immunity; Nucleic Acids; Oral; Pathogenesis; Patient observation; Patients; Peptides; Peripheral Blood Mononuclear Cell; Plasma; Polymerase Chain Reaction; Prevalence; Probiotics; Reporting; Rest; Risk Factors; Role; Running; Sampling; Serology; Shotguns; Surveys; TLR3 gene; Vertebrate Viruses; Virus; Virus Replication; Work; analog; animal model development; bacterial community; bacteriome; base; case control; clinical subtypes; cytokine; density; detection method; dysbiosis; fecal transplantation; fungus; immune function; insight; metabolomics; metagenomic sequencing; microbial; mycobiome; novel; pathogen; response; transcriptome sequencing; virome

Project 1 Microbiology of ME/CFS Abstract Many patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) report a prodrome consistent with infection and/or inflammation. Up to 40% of patients are reported to respond to intravenous infusions of the Toll-like receptor 3 agonist, Ampligen, a double-stranded RNA analogue proposed to inhibit viral replication. Others report responses to antiviral drugs specific for herpesviruses, pre- and probiotics or fecal transplantation, or monoclonal antibodies that deplete B cells. We hypothesize that at least some ME/CFS patients have an infectious trigger for their disease, and that failures to implicate infectious agents reflect inadequate sampling and/or inappropriate assays. To explore the role of infection and immunity in ME/CFS, we will exploit sensitive sequence-based methods for detection and characterization of bacteria, viruses, and fungi, using blood, oral, and fecal samples from well characterized ME/CFS cases and controls. This project has the potential to lead to the development of animal models based on dysbiosis as well as the identification of patients with ME/CFS who may benefit from antiviral, antibiotic, or probiotic interventions.

项目1